Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.8 - $1.74 $12,692 - $27,606
15,866 New
15,866 $13.3 Million
Q4 2022

Feb 14, 2023

BUY
$1.09 - $20.4 $17,293 - $323,666
15,866 New
15,866 $20,000
Q3 2021

Nov 12, 2021

SELL
$3.14 - $3.9 $22,388 - $27,807
-7,130 Reduced 31.01%
15,866 $55,000
Q2 2021

Aug 11, 2021

SELL
$3.8 - $4.56 $393,942 - $472,730
-103,669 Reduced 81.85%
22,996 $89,000
Q1 2021

May 13, 2021

SELL
$4.33 - $6.63 $1,013 - $1,551
-234 Reduced 0.18%
126,665 $582,000
Q4 2020

Feb 09, 2021

SELL
$4.87 - $17.29 $60,237 - $213,860
-12,369 Reduced 8.88%
126,899 $767,000
Q3 2020

Nov 12, 2020

SELL
$15.08 - $27.04 $19,257 - $34,530
-1,277 Reduced 0.91%
139,268 $2.29 Million
Q2 2020

Aug 12, 2020

BUY
$14.57 - $23.96 $164,029 - $269,741
11,258 Added 8.71%
140,545 $3.28 Million
Q1 2020

May 06, 2020

BUY
$10.27 - $21.23 $149,428 - $308,896
14,550 Added 12.68%
129,287 $1.92 Million
Q4 2019

Feb 14, 2020

BUY
$8.36 - $23.81 $119,681 - $340,863
14,316 Added 14.26%
114,737 $2.35 Million
Q3 2019

Nov 07, 2019

SELL
$9.83 - $14.82 $35,496 - $53,515
-3,611 Reduced 3.47%
100,421 $987,000
Q2 2019

Aug 12, 2019

BUY
$12.9 - $20.8 $238,650 - $384,800
18,500 Added 21.63%
104,032 $1.4 Million
Q1 2019

May 14, 2019

BUY
$17.7 - $24.93 $14,868 - $20,941
840 Added 0.99%
85,532 $1.68 Million
Q4 2018

Feb 11, 2019

BUY
$19.05 - $36.45 $84,943 - $162,530
4,459 Added 5.56%
84,692 $1.92 Million
Q3 2018

Nov 09, 2018

BUY
$34.41 - $44.23 $409,547 - $526,425
11,902 Added 17.42%
80,233 $0
Q2 2018

Aug 06, 2018

SELL
$39.21 - $50.29 $27,682 - $35,504
-706 Reduced 1.02%
68,331 $2.68 Million
Q1 2018

May 15, 2018

BUY
$41.7 - $64.16 $217,507 - $334,658
5,216 Added 8.17%
69,037 $3.39 Million
Q4 2017

Feb 09, 2018

BUY
$28.58 - $49.91 $1.82 Million - $3.19 Million
63,821
63,821 $2.89 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.